Showing results (1931-1940 of 2,055) with videos related to
Sort By:
Pageof 206
Molecular Cell|August 5, 2019
The Magnitude of IFN-γ Responses Is Fine-Tuned by DNA Architecture and the Non-coding Transcript of Ifng-as1Franziska Petermann, Aleksandra Pękowska, Catrina A Johnson, et al.Molecular Cancer Therapeutics|February 10, 2012
SKLB1206, a novel orally available multikinase inhibitor targeting EGFR activating and T790M mutants, ErbB2, ErbB4, and VEGFR2, displays potent antitumor activity both in vitro and in vivoYouli Pan, Yong Xu, Shan Feng, et al.Science Immunology|August 19, 2018
Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complementGiuseppe Lofano, Matthew J Gorman, Ashraf S Yousif, et al.Chemical Communications (Cambridge, England)|December 21, 2023
A bivalent inhibitor against TDRD3 to suppress phase separation of methylated G3BP1Wei-Wei Fan, Tian Xu, Jia Gao, et al.Scientific Reports|December 14, 2025
A novel, non-spirometric "BMP index" for predicting severe adverse outcomes in fibrosing interstitial lung diseasesTang-Hsiu Huang, Hsin-Yu Hou, Han-Yu Chang, et al.Science Advances|April 2, 2020
Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancerPreethi Korangath, James D Barnett, Anirudh Sharma, et al.Journal of Breast Cancer|November 20, 2023
Multidisciplinary Shared Decision Making for Fertility Preservation in Young Women With Breast CancerSoo Yeon Baek, Hong-Kyu Kim, Seho Park, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 16, 2024
Computer-assisted image analysis of preexisting histological patterns of the cephalic vein to predict wrist arteriovenous fistula non-maturationJeng-Wei Chen, Mao Ting, Po-Ya Chang, et al.Journal of the American Chemical Society|January 6, 2026
Thermally Driven Solid-Phase Ion Exchange for In Situ Transition from Heterocore-Shell to Alloy NanostructuresYu-Tao Wang, Yi-Meng Yu, Li Ge Chang, et al.Clinical and Translational Medicine|December 23, 2024
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysisShang-Gin Wu, Chao-Chi Ho, James Chih-Hsin Yang, et al.Pageof 206